Aegon trades Bermuda for Delaware and US GAAP

Aegon has filed the paperwork to become Transamerica Inc., and the document is best read as a capital-rules statement: the legal home is following the earnings, and the earnings are American. The F-4 registration statement, reported by Insurance Business America, puts the redomiciliation from Bermuda to the United States before shareholders at an Extraordinary General Meeting expected on Oct. 8, 2026. If approved, the company would change its jurisdiction of incorporation to Delaware and take the name of the US life insurance and retirement subsidiary that now represents roughly 70% of total operations and is the largest contributor to group profit and cash flow.

The redomiciliation is targeted to take effect around Jan. 1, 2028, once Aegon receives a certificate of discontinuance from Bermuda's Registrar of Companies, with the timeline still subject to the shareholder vote and other regulatory conditions. Aegon has framed the shift as aligning its legal domicile, tax residency, accounting standards, and governance with where the bulk of its actual business now sits. Everything about the mechanics points the same way: a group that wants to be read as American.

Aegon first sketched this direction at its December 2025 Capital Markets Day, when it set out an ambition to become a leading US life insurance and retirement group and confirmed New York City as the location for its future head office. The F-4 adds the mechanics: a move to US GAAP reporting, with the first full-year results under the new standard expected for 2027; a proposal to convert all outstanding Common Shares B on a 40-to-1 basis; and a shift toward Delaware and New York Stock Exchange rules governing future stockholder matters. The share conversion changes the company's equity optics, and US GAAP changes how investors will read the group's numbers.

The shareholder circular also contains the political math: Vereniging Aegon, the company's largest shareholder, holds approximately 18.4% of currently exercisable voting rights and has committed under a Voting Undertaking Agreement to vote in favor of both the redomiciliation and the related Omnibus Incentive Plan. That gives the proposal a substantial bloc of committed support heading into the October meeting, making the outcome close to a formality unless the other regulatory conditions intervene.

Aegon has made this trip before. The company redomiciled from the Netherlands to Bermuda in 2023, a move tied to regulatory and supervisory considerations following the earlier combination of its Dutch insurance business with a.s.r. The latest step continues that trajectory, moving the legal home a second time in under three years—this time toward a business mix dominated by its American operations.

The 2023 Bermuda move was an exit from a European regulatory context; the 2028 move is an entry into the US corporate and disclosure framework, with Delaware law, US GAAP, and NYSE governance rules all pointing the same way. As this publication has argued, Bermuda has become a preferred balance sheet for asset managers sourcing longevity capital through sidecar reinsurers. Aegon is making the opposite choice: giving up the Bermuda wrapper for a Delaware incorporation, US GAAP, and a name that tells investors exactly which side of the group is in charge.

The trade makes sense. A company whose cash flow is roughly 70% American cannot keep its legal home in a jurisdiction that this market mainly associates with alternative capital vehicles and sidecar transactions; that split would invite a permanent discount from US investors who want to read the group the way they read other US life insurers. The 40-to-1 share conversion looks like an attempt to present a clean capital structure on the NYSE, and the US GAAP transition suggests the group wants to be compared with American peers. The commitment from an 18.4% shareholder makes the vote less a contest than a countdown. The date to watch after approval is Jan. 1, 2028, when the redomiciliation is targeted to take effect; the first full-year results under US GAAP are expected in 2027.